New hope for hepatitis b patients in experimental treatment trial

NCT ID NCT04856085

Ongoing Disease control Sponsor: Vir Biotechnology, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing whether new drug combinations can help control chronic hepatitis B infection. Researchers are giving 244 adults with long-term hepatitis B different combinations of experimental drugs to see if they're safe and effective. The main goal is to see if these treatments can reduce or eliminate signs of the virus in the blood, potentially allowing some patients to stop their current medications.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Investigative Site

San Francisco, California, 94143, United States
Investigative Site

Miami, Florida, 33136, United States
Investigative Site

Orlando, Florida, 32803, United States
Investigative Site

Baltimore, Maryland, 21218, United States
Investigative Site

Hillsborough, New Jersey, 08844, United States
Investigative Site

Toronto, 2C4, Canada
Investigative Site

Toronto, 3M1, Canada
Investigative Site

Vancouver, 2C7, Canada
Investigative Site

Frankfurt, 60590, Germany
Investigative Site

Hanover, 30625, Germany
Investigative Site

Mannheim, 68167, Germany
Investigative Site

Hong Kong, Shatin, Hong Kong
Investigative Site

Hong Kong, Tai Po District, Hong Kong
Investigative Site

Hong Kong, Hong Kong
Investigative Site

Kuala Lumpur, 59100, Malaysia
Investigative Site

Chisinau, MD 2025, Moldova
Investigative Site

Auckland, 1010, New Zealand
Investigative Site

Auckland, 2025, New Zealand
Investigative Site

Hamilton, 3204, New Zealand
Investigative Site

Tauranga, 3110, New Zealand
Investigative Site

Wellington, 6021, New Zealand
Investigative Site

Bucharest, 021105, Romania
Investigative Site

Busan, 49421, South Korea
Investigative Site

Seoul, 03080, South Korea
Investigative Site

Seoul, 05505, South Korea
Investigative Site

Yangsan, 50612, South Korea
Investigative Site

Chiayi City, 60041, Taiwan
Investigative Site

Kaohsiung City, 80756, Taiwan
Investigative Site

Kaohsiung City, 83301, Taiwan
Investigative Site

Taichung, 40705, Taiwan
Investigative Site

Taipei, 100, Taiwan
Investigative Site

Taoyuan, 33305, Taiwan
Investigative Site

Kyiv, 01135, Ukraine
Investigative Site

Birmingham, B15 2TH, United Kingdom
Investigative Site

London, E11FR, United Kingdom
Investigative Site

London, SE5 9RS, United Kingdom
Investigative Site

Manchester, M8 5RB, United Kingdom

Conditions

Explore the condition pages connected to this study.

HEPATITIS B CHRONIC